Menu
Currency
GWAS Study

Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.

Childs EJ, Mocci E, Campa D et al.

26098869 PubMed ID
GWAS Study Type
21494 Participants
36 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

CE
Childs EJ
ME
Mocci E
CD
Campa D
BP
Bracci PM
GS
Gallinger S
GM
Goggins M
LD
Li D
NR
Neale RE
OS
Olson SH
SG
Scelo G
AL
Amundadottir LT
BW
Bamlet WR
BM
Bijlsma MF
BA
Blackford A
BM
Borges M
BP
Brennan P
BH
Brenner H
BH
Bueno-de-Mesquita HB
CF
Canzian F
CG
Capurso G
CG
Cavestro GM
CK
Chaffee KG
CS
Chanock SJ
CS
Cleary SP
CM
Cotterchio M
FL
Foretova L
FC
Fuchs C
FN
Funel N
GM
Gazouli M
HM
Hassan M
HJ
Herman JM
HI
Holcatova I
HE
Holly EA
HR
Hoover RN
HR
Hung RJ
JV
Janout V
KT
Key TJ
KJ
Kupcinskas J
KR
Kurtz RC
LS
Landi S
LL
Lu L
ME
Malecka-Panas E
MA
Mambrini A
MB
Mohelnikova-Duchonova B
NJ
Neoptolemos JP
OA
Oberg AL
OI
Orlow I
PC
Pasquali C
PR
Pezzilli R
RC
Rizzato C
SA
Saldia A
SA
Scarpa A
SR
Stolzenberg-Solomon RZ
SO
Strobel O
TF
Tavano F
VY
Vashist YK
VP
Vodicka P
WB
Wolpin BM
YH
Yu H
PG
Petersen GM
RH
Risch HA
KA
Klein AP
Chapter II

Abstract

Summary of the research findings

Pancreatic cancer is the fourth leading cause of cancer death in the developed world. Both inherited high-penetrance mutations in BRCA2 (ref. 2), ATM, PALB2 (ref. 4), BRCA1 (ref. 5), STK11 (ref. 6), CDKN2A and mismatch-repair genes and low-penetrance loci are associated with increased risk. To identify new risk loci, we performed a genome-wide association study on 9,925 pancreatic cancer cases and 11,569 controls, including 4,164 newly genotyped cases and 3,792 controls in 9 studies from North America, Central Europe and Australia. We identified three newly associated regions: 17q25.1 (LINC00673, rs11655237, odds ratio (OR) = 1.26, 95% confidence interval (CI) = 1.19-1.34, P = 1.42 × 10(-14)), 7p13 (SUGCT, rs17688601, OR = 0.88, 95% CI = 0.84-0.92, P = 1.41 × 10(-8)) and 3q29 (TP63, rs9854771, OR = 0.89, 95% CI = 0.85-0.93, P = 2.35 × 10(-8)). We detected significant association at 2p13.3 (ETAA1, rs1486134, OR = 1.14, 95% CI = 1.09-1.19, P = 3.36 × 10(-9)), a region with previous suggestive evidence in Han Chinese. We replicated previously reported associations at 9q34.2 (ABO), 13q22.1 (KLF5), 5p15.33 (TERT and CLPTM1), 13q12.2 (PDX1), 1q32.1 (NR5A2), 7q32.3 (LINC-PINT), 16q23.1 (BCAR1) and 22q12.1 (ZNRF3). Our study identifies new loci associated with pancreatic cancer risk.

7,638 cases, 7,364 controls

Chapter III

Study Statistics

Key metrics and study information

21494
Total Participants
GWAS
Study Type
Yes
Replicated
2,287 cases, 4,205 controls
Replication Participants
NR, European, European, NR, Hispanic or Latin American, African unspecified, Asian unspecified
Ancestry
Poland, Czech Republic, Italy, Greece, Germany, Lithuania, U.S., Australia, Canada
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.